ATE486128T1 - Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine - Google Patents

Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine

Info

Publication number
ATE486128T1
ATE486128T1 AT06840107T AT06840107T ATE486128T1 AT E486128 T1 ATE486128 T1 AT E486128T1 AT 06840107 T AT06840107 T AT 06840107T AT 06840107 T AT06840107 T AT 06840107T AT E486128 T1 ATE486128 T1 AT E486128T1
Authority
AT
Austria
Prior art keywords
methods
compositions
production
increase
carboxylated proteins
Prior art date
Application number
AT06840107T
Other languages
English (en)
Inventor
Reidar Wallin
Original Assignee
Univ Wake Forest Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest Health Sciences filed Critical Univ Wake Forest Health Sciences
Application granted granted Critical
Publication of ATE486128T1 publication Critical patent/ATE486128T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6437Coagulation factor VIIa (3.4.21.21)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6432Coagulation factor Xa (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06840107T 2005-12-02 2006-12-04 Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine ATE486128T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74207605P 2005-12-02 2005-12-02
US78205606P 2006-03-14 2006-03-14
PCT/US2006/061575 WO2007065173A2 (en) 2005-12-02 2006-12-04 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins

Publications (1)

Publication Number Publication Date
ATE486128T1 true ATE486128T1 (de) 2010-11-15

Family

ID=38092974

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06840107T ATE486128T1 (de) 2005-12-02 2006-12-04 Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine

Country Status (7)

Country Link
US (2) US8647868B2 (de)
EP (1) EP1963506B1 (de)
AT (1) ATE486128T1 (de)
AU (1) AU2006320168B2 (de)
CA (1) CA2632794C (de)
DE (1) DE602006017882D1 (de)
WO (1) WO2007065173A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004025157D1 (de) 2003-09-23 2010-03-04 Univ North Carolina Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
ES2344413T3 (es) 2003-10-14 2010-08-26 Baxter International Inc. Polipeptido vkorc1 de reciclaje de la vitamina k-epoxido, una diana terapeutica de la cumarina y sus derivados.
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
US20090325226A1 (en) 2005-03-15 2009-12-31 Stafford Darrel W Methods and Compositions for Producing Active Vitamin K-Dependent Proteins
MX2007012704A (es) 2005-04-13 2008-01-14 Astrazeneca Ab Celula huesped que comprende vector para la produccion de proteinas que requieren carboxilacion-gamma.
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
WO2011003153A1 (en) * 2009-07-10 2011-01-13 Csl Limited Method of increasing the expression yield of vitamin k-dependent proteins
US9896677B2 (en) 2010-01-18 2018-02-20 Novo Nordisk Health Care Ag Purification of blood coagulation factors
EP2655607A4 (de) 2010-12-21 2014-05-14 Univ North Carolina Verfahren und zusammensetzungen zur herstellung aktiver vitamin-k-abhängiger proteine
EP3305810A4 (de) * 2015-05-27 2018-04-25 Fundacao Hemocentro de Ribeirao Preto Verfahren zur herstellung von blutgerinnungsfaktor vii sowie blutgerinnungsfaktor vii
BR102015012334A2 (pt) 2015-05-27 2016-11-29 Fundação Hemoct De Ribeirão Preto Fundherp processo de produção do fator vii de coagulação sanguínea e fator vii de coagulação sanguínea

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106657A2 (en) * 2002-06-14 2003-12-24 Stowers Institute For Medical Research Wise/sost nucleic acid sequences and amino acid sequences
US8609370B2 (en) * 2004-02-13 2013-12-17 Glycotope Gmbh Highly active glycoproteins-process conditions and an efficient method for their production
US20060073117A1 (en) * 2004-10-01 2006-04-06 Stowers Institute For Medical Research Methods and compositions for controlling hair follicle stem cell fate
WO2006056028A2 (en) * 2004-11-23 2006-06-01 K.U. Leuven Research & Development Autism genes and regulated secretion
WO2006067116A1 (en) 2004-12-21 2006-06-29 Novo Nordisk Health Care Ag Expression of gamma-carboxylated polypeptides in gamma-carboxylation deficient host systems
EP2295547B1 (de) * 2005-02-28 2017-09-20 Baxalta GmbH Rekombinante co-Expression der Vitamin-K-Epoxide-Reduktase-Untereinheit 1 zur Verbesserung der Expression Vitamin-K-abhängiger Proteine
MX2007012704A (es) * 2005-04-13 2008-01-14 Astrazeneca Ab Celula huesped que comprende vector para la produccion de proteinas que requieren carboxilacion-gamma.

Also Published As

Publication number Publication date
US8647868B2 (en) 2014-02-11
US20100331255A1 (en) 2010-12-30
CA2632794C (en) 2015-04-07
EP1963506A2 (de) 2008-09-03
EP1963506A4 (de) 2009-01-07
AU2006320168B2 (en) 2012-02-23
WO2007065173A2 (en) 2007-06-07
DE602006017882D1 (de) 2010-12-09
US20140227248A1 (en) 2014-08-14
EP1963506B1 (de) 2010-10-27
AU2006320168A1 (en) 2007-06-07
WO2007065173A3 (en) 2008-07-03
CA2632794A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
NL301145I2 (nl) Tirbanibulin
CO6501191A2 (es) Medio de cultivo celular para expresión de la proteina adamts
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
MX2009005655A (es) Composiciones y usos de un polipeptido alfa-amilasa del bacilo de la especie 195.
WO2011047087A3 (en) Protein detection via nanoreporters
MX2010004674A (es) Variantes de alfa-amilasa con propiedades alteradas.
MX2008001538A (es) Aril piridinas y metodos para su uso.
SG165339A1 (en) Incorporation of non-naturally encoded amino acids into proteins
WO2006069719A3 (en) Lyophilization of virosomes
DK2002016T3 (da) Fremgangsmåde til bestemmelse af kopital
MY146352A (en) Adipose derived adult stem cells in hepatic regeneration
ATE501268T1 (de) Vorrichtungen und verfahren zur bestimmung von proteaseaktivität
MY173526A (en) Novel anti-?5?1 antibodies and uses thereof
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
MX341064B (es) Variantes de la familia il-1.
ATE497779T1 (de) Enzyme zur reduzierung von immunologischem stress
DE602007012412D1 (de) Rekombinante produktion heparinbindender proteine
MY162185A (en) Alumina particles and methods of making the same
EP1885867A4 (de) Neue verfahren
MX2009012643A (es) Particulas de alumina y metodos para fabricar las mismas.
TW200738752A (en) Modulation of MDL-1 activity for treatment of inflammatory disease
ATE420162T1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
WO2010123885A3 (en) Iga1 protease polypeptide agents and uses thereof
WO2014009849A3 (en) Stabilized laccase enzyme and methods of making and using the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1963506

Country of ref document: EP